Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
34 |
Employees |
2 |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-4 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Spotlight Innovation Inc.
Spotlight Innovation Inc. is a biotechnology company headquartered in Utah, United States. The company focuses on identifying and acquiring early-stage healthcare technologies. Their goal is to enhance these technologies through strategic consulting, intellectual property rights, licensing, and development support.
Spotlight Innovation Inc. primarily focuses on developing innovative therapeutics for the treatment of various diseases and medical conditions, including cancer, neurological disorders, and rare genetic diseases. They collaborate with research institutions, universities, and other partners to advance their pipeline of product candidates.
The company also operates the subsidiary Celtic Biotech Iowa LLC, which is engaged in the development and commercialization of therapeutic compounds derived from snake venom. Through this subsidiary, Spotlight Innovation aims to discover new treatments for cancer and other diseases.
Spotlight Innovation Inc. actively seeks out promising technologies and provides the necessary capital, guidance, and resources to accelerate their development and commercialization. Their business model revolves around identifying breakthrough healthcare advancements and transforming them into successful commercial products to benefit patients and healthcare providers worldwide.
|